Studies have shown that the SPHK/S1P signal pathway activates the p38-GSK3β-β-catenin pathway, promoting osteoblast formation with elevated S1P2 expression in relapsed AML patients. This evidence concerns the gene SPHK1 and acute myeloid leukemia.